Key result
ShMOLLI ECV mapping outperforms MOLLI in detecting severe myocardial fibrosis.
Why the study?
To histologically validate T1 mapping for quantitative assessment of mild-to-severe myocardial fibrosis in a swine model of chronic myocardial infarction.
Does cardiac MRI T1 and ECV mapping accurately detect myocardial fibrosis compared to histopathology in a swine model of chronic MI?
Does cardiac MRI T1 and ECV mapping accurately detect myocardial fibrosis compared to histopathology in a swine model of chronic MI?
Cardiac MRI T1 and ECV mapping, particularly using ShMOLLI, accurately quantifies severe myocardial fibrosis in a swine model of chronic MI when validated against histopathology.
Answers are grounded in this paper and cite their sources.
T1 mapping should not yet guide clinical fibrosis assessment; leaves open human translation despite swine histologic validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied Chronic myocardial infarction and myocardial fibrosis (n=18). Extracellular volume fraction (ECV) mapping using ShMOLLI vs. ECV mapping using MOLLI was evaluated on Diagnostic performance for detecting severe myocardial fibrosis (AUC). Extracellular volume fraction mapping using ShMOLLI showed higher diagnostic performance than MOLLI for detecting severe myocardial fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: